Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price rose 6.4% during trading on Thursday . The stock traded as high as $22.08 and last traded at $22.28. Approximately 230,924 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 1,787,012 shares. The stock had previously closed at $20.94.
Wall Street Analyst Weigh In
ACHC has been the topic of several research analyst reports. Stephens raised shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Guggenheim began coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. Bank of America dropped their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Finally, Mizuho cut their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research note on Wednesday, May 14th. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.
View Our Latest Stock Analysis on ACHC
Acadia Healthcare Trading Up 5.3%
The stock's fifty day moving average price is $22.90 and its two-hundred day moving average price is $32.05. The stock has a market capitalization of $2.03 billion, a P/E ratio of 10.86, a price-to-earnings-growth ratio of 4.03 and a beta of 0.94. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.35 by $0.05. The business had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The company's revenue for the quarter was up .3% on a year-over-year basis. During the same period in the prior year, the business earned $0.84 EPS. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. FMR LLC increased its holdings in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after purchasing an additional 4,489,681 shares in the last quarter. Citigroup Inc. lifted its stake in Acadia Healthcare by 5,144.2% during the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock valued at $72,047,000 after acquiring an additional 2,330,898 shares during the period. Hawk Ridge Capital Management LP grew its stake in shares of Acadia Healthcare by 437.5% in the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock worth $74,988,000 after acquiring an additional 2,013,126 shares during the period. Madison Avenue Partners LP purchased a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $76,339,000. Finally, Abrams Bison Investments LLC purchased a new stake in Acadia Healthcare in the first quarter worth approximately $55,182,000.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
